Hims & Hers Health (HIMS) Goodwill & Intangibles (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Goodwill & Intangibles came in at $603.9 million in Q1 2026, up 274.65% year-on-year from $161.2 million in Q1 2025, and up 27.28% quarter-over-quarter from $474.4 million in Q4 2025.
Hims & Hers Health (HIMS) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Goodwill & Intangibles across 7 years of filings, most recently posting $603.9 million for Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $603.9 million, up 274.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $603.9 million (up 274.65% YoY), and the FY2025 annual result was $474.4 million, up 203.86% from the prior year.
- Goodwill & Intangibles came in at $603.9 million for Q1 2026 at Hims & Hers Health, up from $474.4 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $603.9 million in Q1 2026 to a low of $46.7 million in Q3 2024.
- The 5-year median for Goodwill & Intangibles is $133.0 million (2022), against an average of $198.2 million.
- Across the five-year window, Goodwill & Intangibles soared 4817.38% in 2022 and sank 64.15% in 2024, its largest moves.
- Hims & Hers Health's Goodwill & Intangibles stood at $132.7 million in 2022, then declined by 2.46% to $129.5 million in 2023, then increased by 20.61% to $156.1 million in 2024, then soared by 203.86% to $474.4 million in 2025, then increased by 27.28% to $603.9 million in 2026.
- The last three Goodwill & Intangibles figures came in at $603.9 million (Q1 2026), $474.4 million (Q4 2025), and $454.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 603.87 Mn |
| Dec 31, 2025 | 474.44 Mn |
| Sep 30, 2025 | 454.17 Mn |
| Jun 30, 2025 | 158.41 Mn |
| Mar 31, 2025 | 161.18 Mn |
| Dec 31, 2024 | 156.14 Mn |
| Sep 30, 2024 | 46.67 Mn |
| Jun 30, 2024 | 128.01 Mn |
| Mar 31, 2024 | 128.74 Mn |
| Dec 31, 2023 | 129.46 Mn |
| Sep 30, 2023 | 130.18 Mn |
| Jun 30, 2023 | 130.84 Mn |
| Mar 31, 2023 | 131.79 Mn |
| Dec 31, 2022 | 132.72 Mn |
| Sep 30, 2022 | 132.97 Mn |
| Jun 30, 2022 | 134.69 Mn |
| Mar 31, 2022 | 135.73 Mn |
| Dec 31, 2021 | 136.77 Mn |
| Sep 30, 2021 | 137.81 Mn |
| Jun 30, 2021 | 2.74 Mn |